Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
You may experience mild side effects such as nausea or decreased appetite
PlexusDx's compounded GLP-1 options (semaglutide and tirzepatide from licensed 503A pharmacies) combined with genetic and biomarker context can support a provider-guided conversation about whether GLP-1-based weight management aligns with your individual health profile and treatment objectives
The study concluded that daily L-carnitine dosages, primarily at 2,000 mg, resulted in a modest, but statistically significant loss in body weight (mean loss 1.21 kg), BMI, and fat mass
Although evidence supports peripheral-central correlation, future studies with cerebrospinal fluid analysis would provide more direct evidence of brain OS changes during ECT
March 14, 2024
This personalized genetic insight helps PlexusDx clinicians fine-tune your treatment from day one, maximizing month-one outcomes and predicting long-term success more accurately than standard protocols
